chr18-62147091-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_176787.5(PIGN):​c.685C>G​(p.His229Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.766 in 1,587,026 control chromosomes in the GnomAD database, including 468,501 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H229R) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.80 ( 48759 hom., cov: 32)
Exomes 𝑓: 0.76 ( 419742 hom. )

Consequence

PIGN
NM_176787.5 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 1.89

Publications

37 publications found
Variant links:
Genes affected
PIGN (HGNC:8967): (phosphatidylinositol glycan anchor biosynthesis class N) This gene encodes a protein that is involved in glycosylphosphatidylinositol (GPI)-anchor biosynthesis. The GPI-anchor is a glycolipid found on many blood cells and serves to anchor proteins to the cell surface. This protein is expressed in the endoplasmic reticulum and transfers phosphoethanolamine (EtNP) to the first mannose of the GPI anchor. Two alternatively spliced variants, which encode an identical isoform, have been reported. [provided by RefSeq, Jul 2008]
PIGN Gene-Disease associations (from GenCC):
  • multiple congenital anomalies-hypotonia-seizures syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Orphanet, ClinGen, PanelApp Australia
  • Fryns syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=9.619225E-7).
BP6
Variant 18-62147091-G-C is Benign according to our data. Variant chr18-62147091-G-C is described in ClinVar as Benign. ClinVar VariationId is 403308.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.887 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PIGNNM_176787.5 linkc.685C>G p.His229Asp missense_variant Exon 9 of 31 ENST00000640252.2 NP_789744.1 O95427A0A024R2C3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PIGNENST00000640252.2 linkc.685C>G p.His229Asp missense_variant Exon 9 of 31 1 NM_176787.5 ENSP00000492233.1 O95427
PIGNENST00000400334.7 linkc.685C>G p.His229Asp missense_variant Exon 8 of 30 1 ENSP00000383188.2 O95427
PIGNENST00000638424.1 linkn.685C>G non_coding_transcript_exon_variant Exon 7 of 29 5 ENSP00000491963.1 A0A1W2PQZ1

Frequencies

GnomAD3 genomes
AF:
0.798
AC:
121287
AN:
152032
Hom.:
48693
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.873
Gnomad AMI
AF:
0.706
Gnomad AMR
AF:
0.814
Gnomad ASJ
AF:
0.817
Gnomad EAS
AF:
0.909
Gnomad SAS
AF:
0.851
Gnomad FIN
AF:
0.753
Gnomad MID
AF:
0.835
Gnomad NFE
AF:
0.743
Gnomad OTH
AF:
0.792
GnomAD2 exomes
AF:
0.788
AC:
190899
AN:
242216
AF XY:
0.786
show subpopulations
Gnomad AFR exome
AF:
0.873
Gnomad AMR exome
AF:
0.826
Gnomad ASJ exome
AF:
0.819
Gnomad EAS exome
AF:
0.912
Gnomad FIN exome
AF:
0.745
Gnomad NFE exome
AF:
0.734
Gnomad OTH exome
AF:
0.784
GnomAD4 exome
AF:
0.762
AC:
1093869
AN:
1434876
Hom.:
419742
Cov.:
38
AF XY:
0.764
AC XY:
545741
AN XY:
714358
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.877
AC:
29071
AN:
33166
American (AMR)
AF:
0.826
AC:
36294
AN:
43952
Ashkenazi Jewish (ASJ)
AF:
0.819
AC:
21129
AN:
25810
East Asian (EAS)
AF:
0.879
AC:
34565
AN:
39330
South Asian (SAS)
AF:
0.845
AC:
72013
AN:
85222
European-Finnish (FIN)
AF:
0.744
AC:
39490
AN:
53056
Middle Eastern (MID)
AF:
0.838
AC:
4786
AN:
5714
European-Non Finnish (NFE)
AF:
0.744
AC:
809995
AN:
1089248
Other (OTH)
AF:
0.784
AC:
46526
AN:
59378
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.399
Heterozygous variant carriers
0
11820
23639
35459
47278
59098
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19818
39636
59454
79272
99090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.798
AC:
121409
AN:
152150
Hom.:
48759
Cov.:
32
AF XY:
0.799
AC XY:
59445
AN XY:
74370
show subpopulations
African (AFR)
AF:
0.873
AC:
36287
AN:
41548
American (AMR)
AF:
0.814
AC:
12445
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.817
AC:
2835
AN:
3472
East Asian (EAS)
AF:
0.908
AC:
4712
AN:
5188
South Asian (SAS)
AF:
0.852
AC:
4109
AN:
4822
European-Finnish (FIN)
AF:
0.753
AC:
7946
AN:
10554
Middle Eastern (MID)
AF:
0.830
AC:
244
AN:
294
European-Non Finnish (NFE)
AF:
0.743
AC:
50515
AN:
67970
Other (OTH)
AF:
0.792
AC:
1672
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1268
2536
3805
5073
6341
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
872
1744
2616
3488
4360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.763
Hom.:
14479
Bravo
AF:
0.806
TwinsUK
AF:
0.742
AC:
2753
ALSPAC
AF:
0.745
AC:
2870
ESP6500AA
AF:
0.878
AC:
3151
ESP6500EA
AF:
0.753
AC:
6121
ExAC
AF:
0.782
AC:
94288
Asia WGS
AF:
0.864
AC:
2992
AN:
3460

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Multiple congenital anomalies-hypotonia-seizures syndrome 1 Benign:4
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Mar 11, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.043
BayesDel_addAF
Benign
-0.68
T
BayesDel_noAF
Benign
-0.61
CADD
Benign
15
DANN
Benign
0.65
DEOGEN2
Benign
0.010
T;.;T;T;T;.;.;.;.;.;T;.;.;T;.;T;.;.;.;.;.;.;.;.;.
Eigen
Benign
-0.79
Eigen_PC
Benign
-0.58
FATHMM_MKL
Benign
0.031
N
LIST_S2
Benign
0.46
.;.;.;.;.;.;T;.;T;T;.;T;T;.;T;T;T;T;.;.;T;T;T;T;T
MetaRNN
Benign
9.6e-7
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
-1.2
N;.;N;N;N;.;.;.;.;.;N;.;.;N;.;N;.;.;.;.;.;.;.;.;.
PhyloP100
1.9
PrimateAI
Benign
0.36
T
PROVEAN
Benign
0.010
.;.;.;N;.;.;.;.;.;.;N;.;.;.;.;.;.;.;.;.;.;.;.;.;.
REVEL
Benign
0.082
Sift
Benign
1.0
.;.;.;T;.;.;.;.;.;.;T;.;.;.;.;.;.;.;.;.;.;.;.;.;.
Sift4G
Benign
1.0
.;.;.;T;.;.;.;.;.;.;T;.;.;.;.;.;.;.;.;.;.;.;.;.;.
Polyphen
0.0
B;.;B;B;B;.;.;.;.;.;B;.;.;B;.;B;.;.;.;.;.;.;.;.;.
Vest4
0.043
MPC
0.027
ClinPred
0.00068
T
GERP RS
3.7
Varity_R
0.10
gMVP
0.35
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9320001; hg19: chr18-59814324; COSMIC: COSV62951859; API